发明名称 |
GENE THERAPY FOR NEUROMETABOLIC DISORDERS |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide a method for treating disorders affecting the central nervous system including neurometabolic disorders such as lysosomal storage diseases, e.g. Niemann-Pick A disease. <P>SOLUTION: The method includes: a composition containing an adeno-associated virus (AAV) vector which contains a transgene encoding a lysosomal hydrolase and a metalloendopeptidase; and a step of contacting an axonal ending of the neuron with a composition containing high titer AAV having a therapeutic transgene so that the AAV vector is axonally transported in a retrograde fashion and the transgene product is expressed distally to the administration site. <P>COPYRIGHT: (C)2012,JPO&INPIT |
申请公布号 |
JP2011251992(A) |
申请公布日期 |
2011.12.15 |
申请号 |
JP20110168292 |
申请日期 |
2011.08.01 |
申请人 |
GENZYME CORP |
发明人 |
PASSINI MARCO A;STEWART GREG;DODGE JAMES |
分类号 |
A61K38/46;A61K35/76;A61K48/00;A61P3/00;A61P25/28;C12N15/864 |
主分类号 |
A61K38/46 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|